InfuSystem Holdings INFU Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 56.7%+3.6pp | 56%+3.8pp | 55.4%+3.5pp | 54.5%+3.9pp | 53.1%+2.4pp | |
| Operating margin | 9.1%+3.0pp | 8.3%+3.2pp | 7.7%+3.5pp | 7.3%+4.3pp | 6.1%+3.4pp | |
| Net margin | 5.6%+3.2pp | 4.6%+2.9pp | 3.9%+2.8pp | 3.6%+3.3pp | 2.3%+2.3pp | |
| EBITDA margin | 18.3%+2.9pp | 17.6%+3.2pp | 17.1%+3.8pp | 16.8%+4.4pp | 15.5%+3.3pp | |
| Free cash flow margin | 16.2%+1.0pp | 16.6%+2.3pp | 17.2%+5.0pp | 18.3%+10.2pp | 15.1%+6.6pp | |
| Returns | ||||||
| Return on equity | 13.9%+8.0pp | 11.5%+7.3pp | 10%+7.2pp | 9.4%+8.7pp | 5.9%+5.8pp | |
| Return on assets | 7.8%+4.7pp | 6.5%+4.2pp | 5.4%+4.0pp | 4.8%+4.5pp | 3.1%+3.0pp | |
| Return on invested capital | 10.2%+5.5pp | 9%+5.1pp | 7.5%+4.4pp | 6.6%+4.5pp | 4.7%+2.8pp | |
| Efficiency | ||||||
| Asset turnover | 1.4×+0.1× | 1.4×+0.1× | 1.4×+0.1× | 1.3×+0.1× | 1.3×+0.1× | |
| Inventory turnover | 10.3×-0.1× | 10.6×+0.6× | 10.2×+0.3× | 10.2×0.0× | 10.4×-0.1× | |
| Liquidity | ||||||
| Current ratio | 2.1×-0.1× | 1.8×0.0× | 1.9×-0.1× | 2.2×+0.1× | 2.2×+0.3× | |
| Quick ratio | 1.8×0.0× | 1.5×+0.1× | 1.6×0.0× | 1.8×+0.2× | 1.8×+0.3× | |
| Cash ratio | 0.1×0.0× | 0.2×+0.1× | 0.1×0.0× | 0×0.0× | 0.1×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.4×-0.2× | 0.4×-0.1× | 0.5×-0.1× | 0.6×-0.2× | 0.6×-0.1× | |
| Debt-to-assets | 0.2×-0.1× | 0.2×0.0× | 0.3×-0.1× | 0.3×-0.1× | 0.3×0.0× | |
| Net debt / EBITDA | 0.8×-0.7× | 0.8×-0.7× | 1×-0.9× | 1.3×-1.2× | 1.6×-0.8× | |
| Interest coverage | 10.6×+5.5× | 9.2×+5.3× | 7.7×+4.9× | 6.6×+4.7× | 5×+3.5× | |
| Per Share | ||||||
| Book value per share | $2.81+7.7% | $2.72+2.5% | $2.65+3.3% | $2.59+5.1% | $2.61+6.0% | |
| Valuation | ||||||
| Market capitalization | $205.05M+51.3% | $182.42M+1.5% | $211.61M+48.3% | $131.31M-9.4% | $113.03M-37.8% | |
| Enterprise value | $227.04M+36.2% | $203.67M-2.6% | $236.77M+34.0% | $162.48M-12.4% | $146.15M-32.8% | |
| Price / earnings | 25.9×-0.8× | 27.5×-49.1× | 38.3×-57.9× | 25.9×-370× | 35.4×-2,126× | |
| Price / sales | 1.4×+0.5× | 1.3×-0.1× | 1.5×+0.4× | 0.9×-0.2× | 0.8×-0.6× | |
| Price / book | 3.5×+1.0× | 3.2×+0.1× | 3.8×+1.2× | 2.4×-0.3× | 2×-1.4× | |
| EV / EBITDA | 8.7×+1.6× | 8.1×-2.7× | 9.8×-0.2× | 6.9×-4.6× | 6.9×-7.1× | |
| EV / sales | 1.6×+0.4× | 1.4×-0.1× | 1.7×+0.3× | 1.2×-0.3× | 1.1×-0.6× | |
| Free cash flow yield | 11.2%-7.7pp | 13.1%+2.3pp | 11.5%+0.1pp | 19.5%+12.2pp | 18.4%+12.4pp | |
| Earnings yield | 3.9%+0.1pp | 3.6%+2.3pp | 2.6%+1.6pp | 3.9%+3.6pp | 2.8%+2.8pp | |
| PEG ratio | 0.2×+0.2× | 0.2×— | 0.1×— | 0×— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are InfuSystem Holdings's profit margins?
- InfuSystem Holdings (INFU) runs a 56.7% gross margin and a 9.1% operating margin, with a 5.6% net margin.
- Where do InfuSystem Holdings's ratios come from?
- Every ratio is computed from InfuSystem Holdings's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
